Status:
COMPLETED
Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic for Treatment of Actinic Keratoses
Lead Sponsor:
Oslo University Hospital
Conditions:
Actinic Keratosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Organ transplant recipients (OTR) have an increased risk of non-melanoma skin cancer, in particular squamous cell carcinoma (SCC), often developing in areas of field cancerization, areas with multiple...
Detailed Description
Protocol for the study: "A randomized half-side comparative trial of fractional laser-assisted daylight photodynamic therapy versus daylight photodynamic therapy in organ transplant recipients with m...
Eligibility Criteria
Inclusion
- Multiple actinic keratoses (\>5) in two symmetrical areas on each side of the scalp or forehead
- OTR with stable graft function
- More than eighteen years of age
- Written informed consent
Exclusion
- Allergy to the MetvixR cream
- Previous PDT treatment less than 6 months ago in treatment areas
- Infiltrating tumor in treatment areas
- Porphyria
- Known tendency to produce hypertrophic scars and keloids
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01898936
Start Date
August 1 2013
End Date
December 1 2016
Last Update
October 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, 0424